- Trials with a EudraCT protocol (27)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
27 result(s) found for: Drug Delivery Systems.
Displaying page 1 of 2.
EudraCT Number: 2009-014696-52 | Sponsor Protocol Number: 17P-ES-003 | Start Date*: 2009-12-31 | |||||||||||
Sponsor Name:AMAG Pharma USA Inc. | |||||||||||||
Full Title: A PHASE 3B, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND STUDY OF HYDROXYPROGESTERONE CAPROATE INJECTION, 250 MG/ML, VERSUS VEHICLE FOR THE PREVENTION OF PRETERM BIRTH IN WOMEN WITH A PREVIOUS SINGLETON ... | |||||||||||||
Medical condition: Preterm birth | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: HU (Completed) ES (Completed) IT (Completed) CZ (Completed) BG (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-005021-21 | Sponsor Protocol Number: PIPIN | Start Date*: 2018-03-26 | |||||||||||
Sponsor Name:University of Edinburgh [...] | |||||||||||||
Full Title: A feasibility study investigating pravastatin for the prevention of preterm birth in women | |||||||||||||
Medical condition: Preterm Birth | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-004396-51 | Sponsor Protocol Number: ZKS_0021PETN | Start Date*: 2017-06-26 | |||||||||||
Sponsor Name:Friedrich Schiller University | |||||||||||||
Full Title: Pentaerithrityl tetranitrate (PETN) for secondary prevention of intrauterine growth restriction (PETN Trial) | |||||||||||||
Medical condition: Pregnant women at risk of adverse pregnancy outcome due to intrauterine growth retardation identified by impaired uterine Doppler measurements at mid gestation (19+0 - 22+6 weeks of gestation). | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-002015-22 | Sponsor Protocol Number: Strindfors2 | Start Date*: 2022-08-12 | |||||||||||
Sponsor Name:Dept. of Obstetrics and Gynecology, Sodersjukhuset | |||||||||||||
Full Title: A pilot study and randomized placebo-controlled trial on the effect and timing of oral Tranexamic acid (TA) administered prepartum on postpartum haemorrhage after vaginal delivery | |||||||||||||
Medical condition: Postpartum hemorrhage which is defined as bleeding during and after delivery that exceeds 500 ml. It is most commonly due to an atony of the uterus but may also have other causes such as tissue dam... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: SE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-004706-25 | Sponsor Protocol Number: V1290413 | Start Date*: 2014-04-02 |
Sponsor Name:University of Edinburgh (ACCORD) [...] | ||
Full Title: A Feasibility study looking at the use of Glibenclamide and metfoRmin versus stAndard Care in gEstational diabeteS | ||
Medical condition: Gestational Diabetes Mellitus (GDM) | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2016-002092-10 | Sponsor Protocol Number: EVE112-CT03-2016 | Start Date*: 2016-09-10 | |||||||||||
Sponsor Name:Evestra GmbH | |||||||||||||
Full Title: Comparative reference-controlled investigation of bleeding pattern under treatment with a vaginal delivery system (EVE112) containing a fixed dose combination of etonogestrel and ethinylestradiol –... | |||||||||||||
Medical condition: Safety, efficacy and tolerability investigations of a hormonal contraceptive in healthy females aged 18-40 years. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: BG (Completed) PL (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-004011-44 | Sponsor Protocol Number: UofATURRIFIC | Start Date*: 2020-05-20 |
Sponsor Name:The University of Adelaide | ||
Full Title: A randomised trial of URsodeoxycholic acid versus RIFampicin in severe early onset Intrahepatic Cholestasis of pregnancy: the TURRIFIC study, comparing their effectiveness in the reduction of pruri... | ||
Medical condition: Intrahepatic Cholestasis of Pregnancy (ICP) is an serious liver condition in pregnancy. The main symptom of this is itching. Ursodeoxycholic acid is routinely used to treat cholestasis but is not... | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: FI (Ongoing) GB (GB - no longer in EU/EEA) SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2011-001617-14 | Sponsor Protocol Number: CRLX030A2205 | Start Date*: 2012-08-17 | |||||||||||
Sponsor Name:Novartis Pharma Services AG | |||||||||||||
Full Title: An adaptive multicentre, randomized, partially doubleblind, placebo controlled study to assess the safety, PK and PD/efficacy of RLX030 in women with pre-eclampsia | |||||||||||||
Medical condition: Pre-eclampsia | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-005782-12 | Sponsor Protocol Number: P-Monofer-PP-01 | Start Date*: 2013-04-17 | |||||||||||
Sponsor Name:Pharmacosmos A/S | |||||||||||||
Full Title: A, Randomized Comparative, Open-Label Study of Intravenous Iron Isomaltoside 1000 (Monofer®) Administered by High Single Dose Infusions or Standard Medical Care in Women after Postpartum Haemorrhage | |||||||||||||
Medical condition: Postpartum haemorrhage | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-004482-14 | Sponsor Protocol Number: P160917 | Start Date*: 2019-08-14 |
Sponsor Name:ASSISTANCE PUBLIQUE-HOPITAUX DE PARIS (AP-HP) | ||
Full Title: Tocolysis in the management of preterm premature rupture of membranes before 34 weeks of gestation: a double-blinded randomized controlled trial | ||
Medical condition: Pregnant women with PPROM at 22 to 33 weeks gestation | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: FR (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2016-000971-26 | Sponsor Protocol Number: RHF-CAELYX-002 | Start Date*: 2016-04-04 |
Sponsor Name:Charles University in Prague, Medical Faculty | ||
Full Title: Liposoms (drug delivery systems) in kinetically guided therapy of ovarian platinum-resistant carcinoma with doxorubicin using plasmafiltration | ||
Medical condition: Chemotherapy of ovarian platinum-resistant carcinoma | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: CZ (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2013-003144-23 | Sponsor Protocol Number: PANDA | Start Date*: 2014-02-03 | |||||||||||||||||||||
Sponsor Name:King's College London [...] | |||||||||||||||||||||||
Full Title: Pregnancy And chronic hypertension: NifeDipine or labetalol as Antihypertensive treatment | |||||||||||||||||||||||
Medical condition: Chronic hypertension in pregnancy | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||||||||||||
Trial protocol: GB (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2009-017387-16 | Sponsor Protocol Number: GH-3826 | Start Date*: 2010-08-31 |
Sponsor Name:Novo Nordisk Pharmaceutique S.A.S | ||
Full Title: To assess ease of use, acceptability and preference of Norditropin NordiFlex® in subjects on prescribed growth hormone therapy | ||
Medical condition: children aged 6 years or more receiving growth hormone therapy for the following approved indications (according to Norditropine SPC) -GHD -Turner Syndrome -small for gestational age -chronic rena... | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: FR (Completed) | ||
Trial results: View results |
EudraCT Number: 2018-002904-14 | Sponsor Protocol Number: C14101 | Start Date*: 2019-06-03 |
Sponsor Name:Pharming Technologies B.V. | ||
Full Title: A Phase I/II, Open Label, Proof of Concept Study to investigate Tolerability and Safety of Treatment with Recombinant Human C1 Inhibitor in Patients with Preeclampsia. | ||
Medical condition: Preeclampsia | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: NL (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2007-002978-62 | Sponsor Protocol Number: 2007/13 | Start Date*: 2009-03-18 | ||||||||||||||||
Sponsor Name:Hopital Foch | ||||||||||||||||||
Full Title: Influence de l’analgésie peropératoire (sufentanil administré selon les critères usuels ou rémifentanil administré par un système automatisé à partir de l’Index Bispectral) sur la consommation de m... | ||||||||||||||||||
Medical condition: general anesthesia | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: FR (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-003410-12 | Sponsor Protocol Number: RG_19-169 | Start Date*: 2020-12-16 |
Sponsor Name:University of Birmingham | ||
Full Title: Pregnancy ANtihypertensive Drugs: which Agent is best? | ||
Medical condition: Hypertension in pregnancy (chronic hypertension, gestational hypertension or pre-eclampsia) | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: GB (GB - no longer in EU/EEA) | ||
Trial results: (No results available) |
EudraCT Number: 2014-002544-40 | Sponsor Protocol Number: 5866 | Start Date*: 2014-10-29 |
Sponsor Name:Hôpitaux Universitaires de Strasbourg | ||
Full Title: THE TREATMENT OF HYPERTENSION ASSOCIATED WITH SEVERE PREECLAMPSIA. A RANDOMIZED CONTROLLED TRIAL OF URAPIDIL VERSUS NICARDIPINE. The URANIC trial. | ||
Medical condition: Hypertension associated with severe pre eclampsia | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: FR (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2014-000084-40 | Sponsor Protocol Number: NT-05 | Start Date*: 2014-04-07 | |||||||||||
Sponsor Name:Nora Therapeutics, Inc. | |||||||||||||
Full Title: A randomized, double blind, multi-center, placebo-controlled study to evaluate the efficacy, safety, and tolerability of NT100 in pregnant women with a history of unexplained recurrent pregnancy lo... | |||||||||||||
Medical condition: Unexplained recurrent pregnancy loss. A distinct disorder from sporadic pregnancy loss and is characterized by the loss of multiple pregnancies | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-004175-73 | Sponsor Protocol Number: HP-CD-CL-2002 | Start Date*: 2017-09-27 | |||||||||||
Sponsor Name:Herantis Pharma Plc | |||||||||||||
Full Title: A Phase I-II, Randomised, Double-Blind, Placebo Controlled, Safety and Tolerability Study of Intermittent Bilateral Intraputamenal Cerebral Dopamine Neurotrophic Factor (CDNF) Infusions Administere... | |||||||||||||
Medical condition: Idiopathic Parkinson's Disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-000619-58 | Sponsor Protocol Number: 19CH214 | Start Date*: 2021-02-01 | |||||||||||
Sponsor Name:CHU SAINT-ETIENNE | |||||||||||||
Full Title: A pilot study assessing the feasibility of a randomized controlled trial evaluating aspirin in postpartum women at risk of developing venous thromboembolism Pilot PARTUM Trial: Postpartum Aspirin... | |||||||||||||
Medical condition: Post-Partum Venous thromboembolism prophylaxis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: FR (Prematurely Ended) NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.